Remdesivir’s big price tag ignores an enormous investment in its creation by the National Institutes of Health.

Researchers have generated immense data to support that sustained NIH funding is crucial for the emergence of new drugs. It is now up to legislators to make it right by patients.

↩︎ STAT

View Post →